Amorfix Life Sciences Ltd. is a product development company focused on therapeutic antibodies and diagnostics for the diagnosis and treatment of misfolded protein diseases including amyotrophic lateral sclerosis (ALS), cancer and Alzheimer�s disease (AD). The Company is offering two types of products: Therapeutics and Diagnostic Services. The Company's Therapeutics is designed to target and neutralize only the misfolded conformation of a given protein. The Company provides Diagnostic Services using its sensitive and specific Diagnostic Kits to Alzheimer's researchers and prion removal equipment manufacturers. The Company�s product line include ALS Therapeutic Antibody and ALS Therapeutic Vaccine; ALS Diagnostic Test; AD Preclinical A, AD Clinical EP-AD CSF Test; Anti-PrP (ovarian cancer), Anti-Fas (melanoma) and Anti-CD38 (myeloma/leukemia), and Cangene-Amorfix Collaboration.